Evid Invest
Holders — by stockHoldings — by fund

Knoll Capital Management, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001325083

$214.3M

disclosed book value

37

positions

16.3%

largest position share

Positions, as of 2026-06-30

top 37 of 37 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1Biohaven Pharmactl Hldg Co2.4M$35.0M16.3%
2MeiraGTX Holdings1.3M$16.9M7.9%
3PHYSSprott physical gold Trust387,055$11.7M5.4%
4ALDXAldeyra Therapeutics Inc5.5M$11.7M5.4%
5OCULOcular Therapeutix Inc.1.2M$11.3M5.3%
6RGLDRoyal Gold Inc.52,750$10.5M4.9%
7Entera Bio Ltd5.9M$10.4M4.9%
8NUVBNuvation Bio Inc1.6M$9.1M4.2%
9AEMAgnico Eagle Mines Ltd52,750$8.2M3.8%
10SEA1EURSEABRIDGE GOLD INC317,003$8.2M3.8%
11KGCKinross Gold Corp320,000$7.6M3.5%
12OROR Royalties225,000$7.1M3.3%
13SSRMSSR Mining In245,000$6.9M3.2%
14FNVFranco Nev Corp32,000$6.7M3.1%
15BAHBooz Allen Hamilton HLDG COR13,000$5.7M2.7%
16CGAUCenterra Gold Inc359,000$5.7M2.7%
17ELTXElicio Therapeutics Inc1.2M$4.7M2.2%
18ABVXAbivax SA Spons35,000$4.7M2.2%
19PAASPan American Silver100,035$4.5M2.1%
20PSLVSprott Physical silver Trust222,160$4.2M2%
21TFPMTriple Flag Precious Metals115,000$3.4M1.6%
22ABEOAbeona Therapeutics485,515$3.0M1.4%
23GROYGold RTY Corp1.0M$2.8M1.3%
24NEWPNew Pac Metals Corp485,000$1.9M0.9%
25ITAiSHares US Aerospace & Defense7,650$1.9M0.9%
26PMPhilip Morris Intl. Inc10,000$1.8M0.8%
27CDECoeur Mining Inc96,132$1.6M0.7%
28AGIAlamos Gold Inc50,000$1.5M0.7%
29WPMWheaton Precious Metals Corp12,500$1.4M0.7%
30NOCNorthrop Grumman Corp2,165$1.1M0.5%
31ELEElemental RTY Corp50,000$873,0000.4%
32VMETVersamet Royalties Corp66,621$820,6680.4%
33DCDakota Gold Corp122,921$523,6430.2%
34Amrize LTD9,175$489,0270.2%
35ALTAltimmune Inc160,000$486,4000.2%
36PHARPharming Group NV4,091$56,8230%
37Orgenesis, Inc.50,623$20,8230%

Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.